# Chanyuan Wu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chanyuan-wu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,805 |
| Field | Inflammatory Myopathies and Dermatomyositis |
| h-index | 22 |
| i10-index | 40 |
| Last Known Institution | Wuhan University of Technology |
| OpenAlex ID | https://openalex.org/A5042577529 |
| ORCID iD | 0000-0003-2710-9359 |
| Works | 99 |

## Researcher papers

- [Clinical characteristics of immunoglobulin G4–related disease: a prospective study of 118 Chinese patients](https://scholariq.org/papers/clinical-characteristics-of-immunoglobulin-g4-related-disease-a-prospective/)
- [Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis](https://scholariq.org/papers/incidence-of-fractures-among-patients-with-rheumatoid-arthritis-a-systematic/)
- [The role of gut microbiota in the pathogenesis of rheumatic diseases](https://scholariq.org/papers/the-role-of-gut-microbiota-in-the-pathogenesis-of-rheumatic-diseases/)
- [Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China](https://scholariq.org/papers/long-term-survival-and-death-causes-of-systemic-lupus-erythematosus-in-china/)
- [Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis](https://scholariq.org/papers/remission-rate-and-predictors-of-remission-in-patients-with-rheumatoid-arthritis/)
- [Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients](https://scholariq.org/papers/dermatomyositis-and-polymyositis-in-the-intensive-care-unit-a-single-center/)
- [Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis](https://scholariq.org/papers/anti-mda5-antibody-as-a-potential-diagnostic-and-prognostic-biomarker-in/)
- [Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis](https://scholariq.org/papers/tocilizumab-for-refractory-rapidly-progressive-interstitial-lung-disease-related/)
- [Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease](https://scholariq.org/papers/myositis-specific-autoantibodies-in-dermatomyositis-polymyositis-with/)
- [Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis](https://scholariq.org/papers/clinical-efficacy-and-safety-of-sirolimus-in-systemic-lupus-erythematosus-a-real/)
- [Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendations](https://scholariq.org/papers/management-of-newly-diagnosed-lupus-nephritis-in-china-an-implementation-study/)

## Researcher topics

- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)

## Researcher university

- [Wuhan University of Technology](https://scholariq.org/institutions/wuhan-university-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.